Emistat Tablet 8mg

EMISTAT®

ONDANSETRON

Description

Emistat is a selective 5-hydroxytryptamine-3 (5-HT3) receptor antagonist with anti-emetic activity.

Indications

Emistat® is indicated for the prevention and treatment of post-operative nausea and vomiting, and for the management of nausea and

vomiting induced by cytotoxic chemotherapy and radiotherapy.

Supply

Emistat® 4mg Tablet: Each box contains 3x10 tablets in blister pack.

Emistat® 8mg Tablet: Each box contains 3x10 tablets in blister pack.

Emistat® 4ml Injection: Each box contains 2x5s ampoules in blister pack

Emistat® oral solution: Each pack contains 50 ml oral solution in PET bottle with 5 ml spoon and 1.25 ml dropper.

Prescribing Description

[downloads/Emistat oral ins.pdf]